cally inactive S-AGzmA also does not cause mitochondrial proteins to be released. This is in contrast GzmB induces mitochondrial damage by two distinct pathways. One pathway, whose molecular basis is unto GzmB treatment, in which all four of the five known intermembrane apoptogenic factors studied (cytoknown, involves direct action on mitochondria to induce increased ROS and loss of ⌬ψ, but not release of chrome c, HtrA2/Omi, endoG, and AIF) were detected in the supernatant following treatment, provided that cytochrome c and other intermembrane proapoptotic factors (Heibein et (F) GzmA, unlike GzmB, does not induce MOM rupture, as monitored by apoptogenic factor release. Isolated mitochondria were treated for 30 min with GzmA, catalytically inactive S-AGzmA, or GzmB in the presence or absence of cytosol (S100). Immunoblots of the mitochondrial pellet (P) and reaction supernatants (S) were probed with antibodies to cytochrome c (Cyt c), the serine protease HtrA2, endonuclease G (Endo G), and apoptosis inhibitory factor (AIF). Cytosolic β-actin and the mitochondrial internal protein cytochrome c oxidase IV (Cox IV) serve as fractionation controls. These data are representative of three independent experiments.
by chelating Ca 2+ with EGTA, there was no increase in ROS production, even in the presence of specific peptide. As the GzmB cluster knockout mice efficiently express only GzmA, these data strongly suggest that PFN-mediated delivery of GzmA by CTL granule exocytosis induces rapid ROS production in the target cell. Moreover, both murine and human GzmA trigger rapid ROS production in target cells.
GzmA-Induced ROS Accumulation and ⌬ Loss Are Insensitive to bcl-2 Overexpression and Occur Independently of Caspase Activation GzmA-activated cell death is caspase independent, and our results in Figure 1 suggest that mitochondrial damage also occurs by a different pathway than that induced by caspase activation. Overexpression of bcl-2 inhibits caspase-dependent mitochondrial damage. To test the role of the bcl-2/caspase pathway in GzmAinduced mitochondrial disruption, we examined ROS production and mitochondrial ⌬ψ in Jurkat cells transfected to overexpress bcl-2 ( Figure 3A) . GzmA loading caused a dose-dependent increase in intracellular ROS in bcl-2-overexpressing Jurkat cells that was indistinguishable from the increase seen in control cells transfected with the empty vector ( Figure 3B ). As expected, ROS production in Jurkat and Jurkat-bcl-2 cells required treatment with both GzmA and PFN. In addition, the disruption of ⌬ψ seen after the addition of GzmA plus PFN was also insensitive to bcl-2 overexpression ( Figure 3C ). Together, these results demonstrate that delivery of GzmA by PFN into Jurkat cells disrupts mitochondrial function via a pathway that cannot be Superoxide Scavengers Inhibit pore might also block cell death induced by the other Gzms. The CTL experiments were therefore also perGzmA-Induced Cell Death To determine whether increased ROS production was a formed with mouse and human CTLs that express all of the Gzms. Cytotoxicity by mouse CTLs from TCR byproduct of GzmA-induced cell death, or if ROS production itself was necessary for GzmA to cause cell transgenic P14 mice tested against cognate peptidecoated EL4 target cells was also completely inhibited death, we investigated the ability of GzmA to kill K562 cells in the presence of superoxide ion scavengers or PT by the superoxide scavengers Tiron and D1417 and partially inhibited by CsA ( Figure 6D ). Human CTL lines pore inhibitors. Cells were preincubated with dilutions of each drug, starting with the highest concentration that were either lymphokine-activated killer (LAK) cells tested against concanavalin A (conA)-coated K562 was not toxic for the cells (data not shown), and cell death was measured 1 hr after adding GzmA and/or targets ( Figure 6E ) or A2-restricted CMV peptide-specific CTLs tested against peptide-coated autologous PFN by flow cytometry staining for annexin and PI. NAC had no protective effect on GzmA-induced cell death.
B-LCL targets ( Figure 6F ). The inhibitory effects of CsA, Tiron, and D1417 on killing by human CTLs were similar However, when K562 cells were treated with the superoxide scavengers Tiron or D1417, GzmA-induced cell to that obtained with mice cells, with complete inhibition by superoxide scavengers and partial inhibition by death was completely inhibited ( Figure 6A ). Since NAC primarily inhibits the accumulation of free radicals, a CsA. However, D1417 was a somewhat less effective inhibitor in human cells than it was in mouse cells, and process downstream of superoxide production (Kroemer et al., 1998; Zamzami et al., 1996) , these data suggest it required about a log higher concentration for complete inhibition. Because superoxide scavengers prothat superoxide generation is required for inducing cell death in response to GzmA. tected against cell death induced by CTLs from both P14xGzmB −/− mice and GzmB+ P14 mice as well as GzmA loading in the presence of the PT pore inhibitors CsA or BA partially inhibited cell death ( Figure 6B) . from death by CTLs stimulated in different ways from blood lymphocytes from various healthy human doAt the doses used for this experiment, CsA and BA significantly inhibited both ROS production and ⌬ψ loss, nors, we can conclude that superoxide anion generation is essential for the execution of cell death by but the inhibition was incomplete (Figures 4A and 4B) . Therefore, inhibition of GzmA-triggered cell death by GzmB, as well as GzmA. Because the less abundant Gzms (such as GzmC and GzmM) may not have been different types of inhibitors correlates with the ability of the inhibitor to block ROS generation and loss of ⌬ψ.
highly expressed by these CTLs, we cannot be certain whether superoxide scavengers will also block the acThere are two possible explanations of the partial inhibition of cell death by PT pore inhibitors. One possition of these less well-studied Gzms. bility is that GzmA-induced mitochondrial damage and cell death proceeds by both PT pore-dependent and PT sol in untreated K562 cells, whereas, in H 2 O 2 -treated stained in a similar pattern as histone H1. Furthermore, Tiron pretreatment blocked NM23-H1 translocation incells, there was a rapid appearance of these proteins in the nuclear fraction ( Figure 7A ). Although most of duced by GzmA and PFN. SET staining under all these conditions mimicked NM23-H1 staining (data not shown). eachof these proteins remained in the cytosolic fraction, within 1 min of H 2 O 2 treatment, an increase in Taken together, these results demonstrate that the increase in intracellular ROS initiated by GzmA is renuclear SET, pp32, and NM23-H1 was observed, and by 2 min, the amount in the nucleus had stabilized. The sponsible for the translocation of SET complex proteins, and that superoxide plays a key role in this translocation appeared to be coordinate, suggesting that the whole complex translocated together. There process. was no trace of the control protein β-actin in the nuclear fraction, or of histone H1 in the cytoplasmic Discussion fraction, indicating complete separation of the nuclear and cytoplasmic fractions. These data strongly suggest Mitochondria play an important role in caspase-mediated apoptosis, in which disruption of MOM integrity that oxidative stress triggers the nuclear translocation of the SET complex proteins. In this study, we find that generation of ROS, particularly superoxide ion, is critical for the distinct caspasewere concentrated in the cytoplasmic fraction, while, in cells exposed to GzmA plus PFN, the proteins appear in independent cell death pathway triggered by the CTL and NK cell protease GzmA, which has all the morphothe nuclear fraction ( Figure 7C ). When K562 cells were treated with GzmA plus PFN in the presence of Tiron or logical features of apoptosis (model shown in Figure  7E ). The experiments in this study were performed by D1417, however, nuclear translocation of SET, pp32, and NM23-H1 was blocked. using recombinant human GzmA and GzmA-expressing cytotoxic T cells derived from both mice and humans Immunostaining and confocal microscopy also dem- have externalized phosphatidyl serine and become permeabilized to PI (data not shown), suggesting that oxidative stress and its inhibition by superoxide scavengers lends support to our hypothesis that the SET an increase in ROS is a late nonessential phenomenon in this pathway. However, the maximal concentration of complex is an oxidative stress response complex.
GzmA
ROS generation was found to be critical not only for antioxidants tolerated by Jurkat cells was not as high as was used to protect K562 or EL4 target cells from the GzmA pathway, but also for cell death induction via granule exocytosis by CTLs expressing GzmB in addiGzmA or CTL attack. In this study, the superoxide scavengers were most tion to GzmA. These findings were demonstrated by using a variety of CTLs from both humans and mice.
effective not only at preventing ROS generation, but also at protecting cells from GzmA-and CTL-induced Since GzmB activates caspase-dependent apoptosis (as well as caspase-independent cell death), this sugcell death. The PT pore inhibitors provided only partial protection. It is not clear whether this is because only gests that ROS generation may also be critical for some caspase-dependent apoptotic pathways in some cells. Cell Lines, Antibodies, and Reagents Cells were grown in K10 medium (RPMI1640 supplemented with Isolated Mitochondria Assays 10% fetal calf serum, 2 mM glutamine, 2 mM HEPES, 100 units/ Mitochondria and S100 supernatants were freshly prepared from ml penicillin, 100 mg/ml streptomycin). Jurkat-bcl-2 and Jurkat-neo mouse liver as described (Susin et al., 2000) . Mitochondria (0.5 mg/ (kind gifts of John Reed [Torigoe et al., 1994] ) were grown in the ml protein) were incubated with or without S100 supernatant (1 mg/ same medium with 0.4 mg/ml geneticin. CTL lines were generated ml) plus Gzms at indicated concentrations in a total volume of 60 from P14 (Pircher et al., 1989) and P14xGzmB −/− (Pham et al., 1996) l mitochondrial buffer (220 mM sucrose, 68 mM mannitol, 10 mM mouse splenocytes activated with 1 g/ml specific LCMV peptide KCl, 5 mM KH 2 PO 4 , 2 mM MgCl 2 , 0.5 mM EGTA, 5 mM succinate, gp33 (KAVYNFATC) for 1 hr, washed, and cultured in medium to 2 mM rotenone, 10 mM HEPES [pH 7.2]) for 30 min at 37°C. Mitowhich 25 IU/ml recombinant human IL-2 was added every other chondria were stained with 150 M HE for flow cytometry as deday beginning on day 2. Cell lines were used for experiments after scribed above. For detecting release of apoptogenic factors, after 8-15 days of culture. Mice were backcrossed and maintained under centrifugation at 760 × g for 5 min, the mitochondrial pellet and specific pathogen-free conditions. Human LAK cells was generated supernatant fractions were analyzed by immunoblot. from healthy donor peripheral blood mononuclear cells maintained in K10 plus 1000 IU/ml IL-2 for up to 10 days. A CMV-specific CTL line (98% CD3+, 80% CD8+) specific for an A2-restricted CMV epi-ROS Production by Confocal Microscopy EL4 target cells (2 × 10 6 ) were pulsed with 0.5 g/ml specific LCMV tope (NLVPMLATL, 50% of all cells tetramer+) was generated by stimulating normal donor PBMC twice with the cognate peptide Gross, A., Yin, X.M., Wang, K., Wei, M.C., Jockel, J., Milliman, C.,
